Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-13T06:40:00.430Z Has data issue: false hasContentIssue false

Comparison of Escherichia coli Strains as Agents for Bacterial Interference

Published online by Cambridge University Press:  02 January 2015

Rabin O. Darouiche*
Affiliation:
Center for Prostheses Infection, Michael E. Debakey Veterans Affairs Medical Center andBaylor College of Medicine, Houston, Texas
Sarah Riosa
Affiliation:
Center for Prostheses Infection, Michael E. Debakey Veterans Affairs Medical Center andBaylor College of Medicine, Houston, Texas
Richard A. Hull
Affiliation:
Department of Molecular Virology and Microbiology, Michael E. Debakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas
*
Center for Prostheses Infection, Baylor College of Medicine, 1333 Moursund Ave, Ste A221, Houston, TX 77030, (rdarouiche@aol.com)

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Research Briefs
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Darouiche, RO. Infections in patients with spinal cord injury. In: Mandeli, GL, Bennett, JE, Dolin, R, eds. Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Elsevier Churchill Livingstone, 2010:38513856.Google Scholar
2.Darouiche, RO, Donovan, WH, Del Terzo, M, Thornby, JI, Rudy, DC, Hull, RA. Pilot trial of bacterial interference for preventing urinary tract infection. Urology 2001;58:339344.CrossRefGoogle ScholarPubMed
3.Darouiche, RO, Thornby, JI, Cerra-Stewart, C, Donovan, WH, Hull, RA. Bacterial interference for prevention of urinary tract infection: a prospective, randomized, placebo-controlled, double-blind pilot trial. Clin Infect Dis 2005;41:15311534.Google Scholar
4.Trautner, BW, Hull, RA, Darouiche, RO. Escherichia coli 83972 inhibits catheter adherence by a broad spectrum of uropathogens. Urology 2003; 61:10591062.CrossRefGoogle ScholarPubMed
5.Klemm, PV, Roos, V, Ulett, GC, Svanborg, C, Schembri, MA. Molecular characterization of the Escherichia coli asymptomatic bacteriuria strain 83972: the taming of a pathogen. Infect Immun 2006;74:781785.Google Scholar
6.Johnson, JR. Virulence factors in Escherichia colt urinary tract infection. Clin Microbiol Rev 1991;4:80128.Google Scholar
7.Hull, RA, Rudy, DC, Donovan, WH, Wieser, IE, Stewart, C, Darouiche, RO. Virulence properties of Escherichia coli 83972, a prototype strain associated with asymptomatic bacteriuria. Infect Immun 1999;67:429432.CrossRefGoogle ScholarPubMed
8.Hull, RA, Donovan, WH, Del Terzo, M, Stewart, C, Rogers, M, Darouiche, RO. Role of type 1 fimbria- and P fimbria-specific adherence in colonization of the neurogenic human bladder by Escherichia coli. Infect Immun 2002;70:64816484.CrossRefGoogle ScholarPubMed
9.Trautner, BW, Hull, RA, Thornby, JI, Darouiche, RO. Coating urinary catheters with an avirulent strain of Escherichia coli as a means to establish asymptomatic colonization. Infect Control Hosp Epidemiol 2007;28:9294.CrossRefGoogle ScholarPubMed
10.Trautner, BW, Cevallos, ME, Li, H, et al.Increased expression of type 1 fimbriae by nonpathogenic Escherichia coli 83972 results in an increased capacity for catheter adherence and bacterial interference. J Infect Dis 2008;198:899906.CrossRefGoogle Scholar